- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 8
Promethera Biosciences fires its way to series D
UCL spinout Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.
May 8, 2019Investors load up Astroscale series D to $80m
The space debris removal company has raised another $30m for its series D round from investors including UTokyo Innovation Platform and has now received $132m in total.
Apr 15, 2019Ahren adds gravity to Graphcore’s $200m series D
Ahren Innovation Capital has been confirmed as an investor in a round that brought University of Bristol-linked machine intelligence technology developer Graphcore’s total to $310m.
Mar 21, 2019Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Mar 18, 2019ClearMotion rides investor interest to raise $115m
Microsoft, Bridgestone and Qualcomm all contributed to a series D round for MIT spinout ClearMotion, which emerged from stealth earlier last year with $130m in funding.
Jan 11, 2019Itochu kicks off Promethera's series D round
UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.
Jan 4, 2019Graphcore absorbs $200m in series D funding
Bristol-linked Graphcore has raised cash from Microsoft, Samsung, BMW i Ventures, Robert Bosch Venture Capital and Dell Technologies Capital at a valuation of $1.7bn.
Dec 19, 2018AutoGrid charges $32m series D
AutoGrid, the distributed energy management platform backed by Stanford, will use the capital from the Eon, CLP, Innogy, Total, Ørsted and Tenaska-backed round to boost hiring.
Sep 13, 2018PhaseBio attracts $34m in series D round
Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline, based on research from Duke University.
Sep 7, 2018Outset originates $132m series D
Baxter Ventures has participated in a series D round for Outset Medical, a spinout of Oregon State University.
Aug 29, 2018
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.